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Autographa californica multiple nucleopolyhedrovirus ORF34 is part of a transcriptional unit that
includes ORF32, encoding a viral ﬁbroblast growth factor (FGF) and ORF33. We identiﬁed ORF34 as a
candidate for deletion to improve protein expression in the baculovirus expression system based on
enhanced reporter gene expression in an RNAi screen of virus genes. However, ORF34 was shown to be
an essential gene. To explore ORF34 function, deletion (KO34) and rescue bacmids were constructed
and characterized. Infection did not spread from primary KO34 transfected cells and supernatants from
KO34 transfected cells could not infect fresh Sf21 cells whereas the supernatant from the rescue
bacmids transfection could recover the infection. In addition, budded viruses were not observed in
KO34 transfected cells by electron microscopy, nor were viral proteins detected from the transfection
supernatants by western blots. These demonstrate that ORF34 is an essential gene with a possible role
in infectious virus production.
& 2012 Elsevier Inc. All rights reserved.Introduction
Baculoviruses are large rod shaped DNA viruses that infect
insects. They have practical applications as biological insecticides
and protein expression vectors. Autographa californicamulticapsid
nucleopolyhedrovirus (AcMNPV) is the type species of the
Alphabaculovirus genus of the family Baculoviridae (International
Committee on Taxonomy of Viruses, 2009). Two clades, group I
and group II, have been identiﬁed in Alphabaculovirus (Zanotto
et al., 1993), which differ in the envelope fusion protein of the
budded virus (BV) (Ijkel et al., 2000; Pearson et al., 2000).
AcMNPV is member of group I and has a 134 Kb genome encoding
approximately 150 proteins (Rohrmann, 2011). The functions of
approximately 50% of these are known (Cohen et al., 2009).
AcMNPV is a lytic virus and its life cycle involves the production
of two morphological forms of the virus and a regulated cascade
of gene expression (for reviews see (Miller, 1997; Rohrmann,
2011). The ﬁrst form of the virus produced during infection is BV,ll rights reserved.
, 288 Farm Lane, Rm 243,
SA. Fax: þ1 517 432 7061.which is formed when nucleocapsids are transported from their
site of replication and assembly in the nucleus to the plasma
membrane and acquire an envelope as they bud from the infected
cells. The second form, occlusion derived virus (ODV), is produced
late in infection when nucleocapsids retained in the nucleus
acquire an envelope, most likely derived from the inner nuclear
membrane (Braunagel and Summers, 2007), and are occluded in
large protein crystals called occlusion bodies. The primary com-
ponent of the occlusion bodies is a single virus protein called
polyhedrin (polh). AcMNPV gene expression comprises four gene
classes. Immediate early genes, which do not require viral gene
products, and delayed early genes are transcribed by the host RNA
pol II and encode proteins required for virus replication. Late and
very late genes are transcribed by a virus RNA polymerase from
virus-speciﬁc promoters and encode primarily structural proteins.
The very late or occlusion-speciﬁc genes, which encode polh and
another small protein, p10, are expressed to very high levels at
the end of the replication cycle. At this stage in the infection cycle
polh makes up approximately 50% of the newly synthesized
protein in the infected cells. The high-level of expression from
the polh promoter is achieved through the use of the strong virus
RNA polymerase. In addition, the production of large amounts of
virus DNA that accumulates in the nucleus effectively ampliﬁes
Table 1
AcMNPV ORFs silenced by RNAi.
ORF(s) targeted by dsRNA Annotation dsRNA size bp dsRNA template positions in AcMNPV genome (bp)
ORF1 ptpase 451 524–974
ORF3 Ctx 150 2245–2119
ORF21 arif-1 485 16938–16454
ORF46 Odv-e66 497 37898–38394
ORF61 Fp25k 374 49086–48713
ORF94 (Odv-e25) p25 370 79974–80343
ORF105 He65 496 93011–92516
ORF148 Odv-e56 405 130128–129724
ORF15 egt 681 11852–12513
ORF22 pif-2 665 17702–18366
ORF23 692 19020–19711
ORF27 iap1 684 22609–23292
ORF32 fgf 534 27581–27048
ORF34þORF35 (v-ubi) 535 28655–29189
ORF49þORF48þORF47 (PCNA) 540 39713–39174
ORF63þORF64 (gp37) 554 51969–51416
ORF71 iap2 633 61118–61750
ORF109 631 95518–94888
ORF115 pif3 503 99703–99202
ORF119 pif1 616 101140–101755
ORF131 pe/pp34 604 110989–111592
ORF136 (p26)þORF137 (p10)þORF138 (p74) 1172 118536–119707
ORF134 94K 989 115972–114984
ORF106þORF107 601 93750–94334
ORF112þORF113 669 96584–97253
ORF12 480 9108–9480
ORF2 Bro 664 1783–1120
ORF11 640 8853–8214
ORF12 416 9065–9480
ORF13 491 10379–9889
ORF18 563 15119–14557
ORF26 319 22214–22532
ORF29 200 24259–24060
ORF30 507 25531–25025
ORF31 Sod 425 25835–26259
ORF33 474 28235–27762
ORF42 gta 504 34829–35332
ORF43 201 35569–35769
ORF44 354 35768–36121
ORF45 501 36155–36655
ORF51 565 43335–43899
ORF52 340 44708–44369
ORF55 191 46418–46608
ORF56 251 46634–46884
ORF57 461 47073–47533
ORF58 150 47733–47584
ORF60 259 48363–48105
ORF63 403 50820–51222
ORF68 517 58740–59256
ORF69 596 59315–59910
ORF73 251 62302–62052
ORF74 516 63044–62529
ORF78 299 65276–64978
ORF79 303 65602–65300
ORF82 tlp 472 67918–67447
ORF83 p95 605 68012–68616
ORF84 401 71247–71647
ORF86 pnk/pnl 602 73269–72668
ORF87 p15 301 74397–74697
ORF88 cg30 604 75505–74902
ORF91 502 78490–77989
ORF93 423 79523–79945
ORF96 455 84406–84860
ORF108 220 94696–94477
ORF110þORF111 313 96321–95961
ORF114 750 98868–98119
ORF116 150 99958–99809
ORF117 200 99939–100138
ORF118 411 100661–100251
ORF120 201 102321–102521
ORF122 151 102897–102747
ORF123 pk2 531 103561–103031
ORF124 634 103854–104487
ORF129 p24 413 109900–110312
ORF130 gp16 306 110524–110829
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Table 1 (continued )
ORF(s) targeted by dsRNA Annotation dsRNA size bp dsRNA template positions in AcMNPV genome (bp)
ORF132 643 111874–112516
ORF145 205 126310–126514
ORF146 587 127116–126530
ORF149 200 130388–130189
ORF150 207 130189–130751
ORF152 250 132360–132111
ORF153 pe38 621 132695–133315
ORF154 203 133620–133822
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DNA is likely accessible for transcription through the entire
infection cycle because a large proportion (approx. 70%) of viral
DNA synthesized in cells is not packaged (Vanarsdall et al., 2006).
AcMNPV open reading frame 34 (ORF34) is a previously unchar-
acterized late gene that is located from 28,294 to 28,939 bp on the
genome and transcribed in a counterclockwise direction relative to
the circular map (Ayres et al., 1994). ORF34 homologs are found in
all other group I and most group II Alphabaculovirus genomes (Cohen
et al., 2009), and gene knockouts could not be obtained for Bombyx
mori nucleopolyhedrovirus (BmNPV), suggesting that it may be an
essential gene (Rohrmann, 2011). ORF34 is located immediately
upstream of a transcriptional unit that includes ORF33 and ﬁbro-
blast growth factor (fgf) (ORF32) (Detvisitsakun et al., 2005), and is
transcribed in the same direction. A viral ubiquitin gene (ubi)
(ORF35) is located upstream of ORF34 and transcribed in the
opposite direction (Guarino, 1990). While this manuscript was in
revision, a paper describing characterization of an AcMNPV ORF34
deletion mutant was published (Cai et al., 2012). This study
identiﬁed a domain with similarity to S-phase kinase-associated
protein 1 (SKP1), characterized ORF34 expression as both early and
late, and showed the protein localized to both nucleus and cyto-
plasm, but not virions. They also report obtaining viruses with
ORF34 deletions that were characterized by reduced BV production,
smaller plaques, and delayed late gene expression.
In this study we identiﬁed ORF34 as an essential virus gene
that is required for the production of infectious BV. The study
was initiated to identify virus genes that could be deleted from the
AcMNPV genome to improve protein expression in the baculovirus
expression vector system (BEVS). Because secretory proteins,
especially those that are highly glycosylated, and integral mem-
brane proteins (IMPs) are more difﬁcult to express than cyto-
plasmic proteins (Grisshammer and Tate, 1995; Jarvis, 1997), we
focused on a model IMP as a reporter for improved protein
expression. We selected 92 AcMNPV open reading frames (ORFs)
that were not previously shown to be essential for virus replication,
and screened for their impact on the expression of the model
protein gene fused to an enhanced green ﬂuorescent protein (EGFP)
using BEVS by RNAi. We report that dsRNA targeting ORF33
increased expression of the model IMP in this screen, as well as
that of other model proteins expressed using BEVS. However,
deleting ORF33 from the AcMNPV genome failed to enhance
expression of the model IMP. Further investigation using gene
knockouts, RNAi, and qRT-PCR revealed that reduced expression
of ORF34, part of a transcriptional unit that includes ORF33 and fgf,
was responsible for the increased expression of the model IMP.
We were unable to generate recombinant viruses with ORF34
deletions, using bacmid technology. Cells transfected with ORF34
knock-out bacmids resulted in single infected cells. This phenotype
could be rescued by expressing ORF34 inserted at the polh locus. BV
was not observed in transmission electron microscopy of ORF34
knockout bacmids. Together these data demonstrate that ORF34 is
an essential gene that is required for virus spread.Results
Transfecting Sf21 cells with ds33 enhanced the protein production
of integral membrane proteins as well as cytosolic proteins driven
by the polh promoter
To identify AcMNPV genes that affect protein expression in the
baculovirus expression system, we conducted an RNAi screen of
AcMNPV genes. We used a model integral membrane protein,
human transient receptor potential cation channel subfamily V
member 4 (TRPV4), fused to EGFP expressed in a recombinant
AcMNPV from the polh promoter (vTRPV4) for readout. TRPV4
is a receptor cation channel comprised of four subunits with
six predicted transmembrane domains that interact to form a
tetrameric channel similar to voltage dependent Kþ channels
(Everaerts et al., 2010). To conduct the screen we knocked down
each of 92 AcMNPV ORFs using dsRNAs. Fluorescent intensity was
measured using a plate reader. Comparisons of the ﬂuorescence
measurements were made between infected cells treated with
dsRNAs directed against AcMNPV ORFs and that of non-speciﬁc
control dsRNA, the drosophila nautilus gene (dsC). The 92 ORFs
were selected to exclude all genes known to affect virus replication
or budded virus production. A total of 83 dsRNAs were used in the
screen (Table 1), however because some predicted ORFs are very
small and others overlapped with adjacent ORFs, 92 ORFs were
effectively targeted for silencing. To monitor the efﬁciency of gene
silencing during the RNAi screen, dsRNA targeting EGFP (the
reporter gene) was used. The RNAi screen was conducted by
transfecting the Sf21 cells with dsRNAs 18 h prior to infection
with vTRPV4. From the data collected at 48 h post-infection (p.i.),
we observed enhanced ﬂuorescent intensity of the EGFP comparing
to the control when transcripts of several different ORFs were
depleted. Knocking down transcripts in ORF33, using complemen-
tary double-stranded RNA (ds33), showed the highest median
ﬂuorescence intensity (MFI) compared to two controls, dsC and
dsRNA targeting the chloramphenicol acetyl transferase (CAT) gene
(dsCAT), an overall enhancement of 2.3 fold (Fig. 1A). Using in-gel
ﬂuorescence to compare TRPV4-EGFP expression in cells trans-
fected with ds33 with dsC, we found that the fusion protein
product was the correct size (128 kDa) and conﬁrmed that expres-
sion was enhanced 1.5 fold (Fig. 1B). To correlate increased MFI to
the increases in protein production, SDS-PAGE and western blots
were conducted (Fig. 1C). The band intensity of the proteins
isolated from the Sf21 cells transfected with ds33 prior to vTRPV4
infection was 1.8 fold greater than the control. Enhancement was
also detected for the human cannabinoid receptor 2 (CNR2),
a G-protein coupled receptor (GPCR), and cytosolic EGFP expressed
as a non-fusion protein both expressed from the polh promoter,
1.3 and 1.9 fold respectively, when cells were transfected with
ds33 compared to controls prior to infection with the viruses
expressing CNR2 (vCNR2) or EGFP (Fig. 1D and E). This indicated
that enhanced expression from the polh promoter resulting from
ORF33 knockdown was not limited to IMPs.
Fig. 1. Silencing ORF 33 with dsRNA enhanced expression levels of proteins driven by the polh promoter. (A) Median ﬂuorescence intensity (MFI) of Sf21 cells transfected
with ds33 18 h prior to vTRPV4 infection and measured by FACS at 48 h p.i. (B) In-gel ﬂuorescent of TRPV4-EGFP protein from representative experiment shown in (A).
Total proteins extracted from the same number of cells transfected with either ds33 or dsC prior to vTRPV4 infection were run on SDS-PAGE and ﬂuorescence was detected
using a Versadoc imaging system (Bio-Rad). (C) SDS-PAGE and western blot (WB) showing TRPV4-EGFP expression at 48 h p.i. after ORF 33 silencing. Anti-His and anti-
VP39 antibody was used for WB. The SDS-PAGE gel was stained with Coomassie Blue. Relative intensity (RI) of the TRPV4 band was normalized to VP39 and analyzed by
Quantity One software. (D) MFI of human cannibinoid receptor (vCNR2) at 48 h p.i., measured by microplate reader (SpectraMaxs M5). (E) The results of FACS analyzing
the MFI of cells infected with vEGFP at 48 h p.i. after treatment with ds33, dsC or dsGFP. dsGFP was used as an additional control for gene silencing efﬁciency. Standard
errors from three independent experiments are shown on each graph. The signiﬁcance differences were determined by t-test.
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and those of neighboring ORFs on polycistronic transcripts
ORF33 is encoded on the complementary strand of the AcMNPV
genome (nucleotides; 27733–28281 ) as part of a transcriptional
unit that includes fgf (Fig. 2A). Upstream is ORF35, ubi, transcribed
in the opposite direction (Guarino, 1990). In a previous study
three abundant transcripts were detected on northern blots using a
complement probe for fgf (Detvisitsakun et al., 2005). These
transcripts are an early 0.6 kb fgf transcript, a late 1.4 kb ORF33/
fgf transcript, and a late 3.1 kb transcript (Fig. 2A). Only the two
late transcripts (1.4 and 3.1 kb) were detected with a complemen-
tary probe for ORF33. The 3.1 kb transcript hybridized with ORF33
and FGF probes but its start and end sites were not determined
(long dotted line in Fig. 2A) (Detvisitsakun et al., 2005). It is not
known if ORF34 is transcribed as part of the 3.1 kb transcript or
if ORF34 monocistronic transcripts are produced (short dotted line
in Fig. 2A). Of note are two canonical late transcription start sites
upstream of ORF34 within the ubi coding region. To examine the
transcripts spanning this region and determine their expression
levels following treatment with ds33, we used reverse transcrip-
tase and real time PCR.
One-step reverse transcriptase PCR (one-step RT-PCR), using
the primers shown in Fig. 2A, was used on total RNA extracted
from Sf21 cells transfected with ds33 prior to vTRPV4 infection,
harvested at 48 h p.i. and compared to the control. At 22 cycles,
the ORF33 transcripts were reduced in the RNA sample isolated
from cells transfected with ds33 relative to dsCAT (Fig. 2B).
Reductions in ORF34 and FGF transcripts were not apparent fromthis experiment, but were clearly observed in qRT-PCR experiments
(Fig. 3, see below). A similar reduction in transcripts was seen when
multiple ORFs were targeted (34/33, 33/FGF, and 34/33/FGF)
(Fig. 2C). This experiment indicated that polycistronic transcripts
spanned the ORF34/ORF33/FGF region (solid line with asterisk in
Fig. 2A; black box with asterisk in Fig. 2C), however, it was not
determined if the 3.1 kb transcript observed by Detvisitsakun et al.
(2005) is a polycistronic transcript of the three ORFs. A non-speciﬁc
band (arrow, Fig. 2B and C) was observed when the F1 primer was
used. We used this non-speciﬁc band as an internal control to
conﬁrm the change in the level of transcripts detected by F1/R3
(black box, Fig. 2C) in cells transfected with ds33 compared to the
control. Primers speciﬁc to the 28S ribosomal RNA were used as a
second control and showed no difference in band intensity between
the experimental and control samples.
To verify the effects of ds33 on transcripts spanning the
adjacent ORFs in this region, qRT-PCR was performed. We com-
pared the relative levels of ORF33, ORF34, FGF, and TRPV4-EGFP
transcripts in Sf21 cells transfected with ds33 or dsC prior to
vTRPV4 infection (Fig. 3). The level of transcripts detected in the
control was considered one and the relative level of the transcripts
in the cells transfected with ds33 was measured accordingly.
At 24 h p.i., the transcripts in the Sf21 cells transfected with ds33
were reduced by approximately 6, 2, and 15 fold for ORF33, ORF34,
and FGF, respectively, when compared to the control (Fig. 3B).
In contrast, the TRPV4-EGFP transcript increased 2.4 fold. At 48 h
p.i., a similar pattern was observed with reductions of approxi-
mately 3, 2, and 7 fold for ORF33, ORF34, and FGF, respectively, and
a 1.7 fold increase for TRPV4-EGFP (Fig. 3C).
Fig. 2. One-step RT-PCR analysis of transcripts at the ORF 33 locus. (A) Diagram of ORFs and transcripts at the ORF 33 locus (after Detvisitsakun et al., 2005). The viral
ubiquitin gene (ubi), encoded on the opposite strand with transcripts originating within ORF34, is also included in the diagram. Solid arrows are previously mapped
transcripts and dashed lines indicate an observed transcript whose 50 and 30 ends have not been mapped (3.1 Kb) and a putative ORF 34 transcript (X). The solid line (*)
represents a polycistronic message conﬁrmed by one-step RT-PCR. The locations of primers used for analysis are shown. (B) Transcripts through each ORF at 48 h p.i. with
vTRPV4 following transfection with ds33 or dsCAT. ORFs, primer pairs and dsRNAs are indicated. (C) Transcripts across adjacent ORFs as indicated at the top of the panel.
Primer pairs and dsRNAs are indicated. 28S RNA was used as a control. Black box in (C) and * in (A) and (C) indicate a transcript that includes FGF, ORF33 and ORF34.
A non-speciﬁc band (750 bp) was detected when F1 primer was used (arrow, in B and C).
Fig. 3. Analysis by qRT-PCR showed that targeting ORF33 with dsRNA reduces the level of ORF33, ORF34 and FGF transcripts and increased levels of TRPV4-EGFP
transcripts. (A) Diagram showing the locations of primers used for analysis. Relative levels of transcripts in Sf21 cells infected with vTRPV4 following transfection with
ds33 or dsC at 24 (B) and 48 h p.i. (C) dsRNAs are indicated on the X-axis and ampliﬁed transcripts at the top of each graph. Bars indicate standard deviation. Mean relative
expression was calculated based on 2DDCt method (Livak and Schmittgen, 2001; Schmittgen and Livak, 2008). Signiﬁcant differences between transcript levels in ds33
and dsC treated cells are shown (po0.001, po0.05).
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Fig. 4. Knockout of ORF33 did not improve expression of TRPV4-EGFP. (A) Diagram showing gene knockouts at the ORF33 locus. Deletions were made in the TRPV4-EGFP
bacmid by replacement with the CAT gene using l Red recombination. ORFs are drawn to scale. Viruses that included an ORF34 deletion (black box) could not be
recovered. (B) MFI of Sf21 cells 48 h p.i. with knockout viruses relative to parental vTRPV4. Knockout viruses are indicated on the x-axis. (C) MFI of Sf21 cells transfected
with dsRNA as indicated on the x-axis 48 h p.i. with vTRPV4. Data were obtained by FACS. Standard errors from three independent experiments are shown on each graph.
The signiﬁcance differences in ﬂuorescent intensity between controls and experimental treatments were determined by t-test.
T.Z. Salem et al. / Virology 435 (2013) 225–238230ORF33 deletion did not have the same effect on TRPV4-EGFP
expression as dsRNA knockdown
To conﬁrm that knockdown of ORF33 was responsible for the
enhanced expression of TRPV4-EGFP, recombinant viruses with
gene disruptions of each of the genes, both singly and in
combination, in this transcriptional unit were generated. Genes
were replaced with or disrupted by the insertion of the CAT
gene into the TRPV4-EGFP bacmid using l-Red recombination
(Datsenko and Wanner, 2000). For all of the double and triple
deletions, a portion (approximately half of the ORF) at the 50end
of the ﬁrst ORF and a portion (approximately half of the ORF) at
the 30end of the last ORFs were maintained. We were successful in
obtaining recombinant viruses with the following gene disrup-
tions: replacement of ORF33 with CAT (v33KO), replacement of
approximately 100 bp in the middle of ORF33 (v33MKO), replace-
ment of approximately100 bp in the middle of FGF (FGFKO), and
replacement of ORF33 and FGF (v33/FGFKO) (Fig. 4A). However,
we failed to obtain the following recombinant viruses: replace-
ment of 100 bp in the middle of ORF34 (v34KO), replacement of
ORF34 and ORF33 (v34/33KO), and replacement of ORF34, ORF33,
and FGF (v34/33/FGFKO) (boxed in Fig. 4A). When cells were
transfected with any bacmid in which ORF34 was disrupted
we observed ﬂuorescence in many single cells and occasionally
a small ﬂuorescent plaque comprising fewer than 10 infected
cells. However, when supernatants from these transfections were
passaged no ﬂuorescent cells were observed, suggesting that
ORF34 is required for production of infectious BV. FACS was used
to measure the MFI of the Sf21 cells infected with the obtainedviruses (v33KO, v33MKO, FGFKO, and v33/FGFKO) and data were
compared with the MFI of cells infected with vTRPV4 (Fig. 4B).
In contrast to the enhanced expression we observed for the dsRNA
knock-down of ORF33, all recombinant viruses with ORF33 gene
disruptions showed signiﬁcant reductions (pr0.01) in the level
of TRPV4-EGFP expression when compared with vTRPV4. The
reductions were approximately 21%, 18%, 26% and 14% for v33KO,
v33MKO, FGFKO, and v33/FGFKO, respectively.
Because RNAi does not eliminate all transcripts, we were able to
use ds34 in RNAi experiments to explore the possibility that
reduced expression of ORF34 rather than ORF33 might be respon-
sible for enhanced expression of TRPV4-EGFP . For these experi-
ments, each of the ORFs in the transcription unit was targeted both
singly and in combination with dsRNAs complementary to the
central regions of each ORF, to avoid potential regulatory regions
of adjacent ORFs. Changes in ﬂuorescent intensity relative to
the control were measured by ﬂow cytometry (Fig. 4C). There
was a signiﬁcant increase in TRPV4-EGFP expression (pr0.01 for
all except dsFGF po0.05); approximately 35%, 40%, 12%, 34%, 25%,
44% or 37% increases in the MFI when Sf21 cells were transfected
with ds33, ds34, dsFGF, ds33/34, ds33/FGF, ds34/FGF, or ds33/34/
FGF, respectively, compared to the control.
Production of infectious BV is reduced and levels of virus DNA
increases in vTRPV4-infected Sf21 cells transfected with ds33 or ds34
To investigate the effects of knocking down ORFs 33 and 34 on
the virus lifecycle and gain some insight into how this improved
expression of TRPV4-EGFP, we examined the effects of ds33 and
Fig. 5. Transfecting Sf21 cells with ds33 and/or ds34 reduces infectious BVs and increases viral genome retention in the cells. (A) BV production by Sf21 cells that were
transfected with 5 mg dsRNAs as indicated on the x-axis followed by infection with vTRPV4 (MOI 5) at 48 h p.i. (B) BV production by Sf21 cells infected with vTRPV4 or
v33KO (MOI 5) at 48 h p.i. (C) qPCR of intracellular AcMNPV genome and BV DNA (D) for cells transfected with ds33 and ds34, as indicated in A, respectively. Primers were
designed for the vp39 gene and the mean relative fold change (MRFC) was measured. Mean relative expression was calculated based on 2DDCt method (Livak and
Schmittgen, 2001; Schmittgen and Livak, 2008). The signiﬁcant differences between the tested samples (ds33 and ds34) and the control (dsC) are shown as p-values.
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infected cells. Sf21 cells were transfected with ds33, ds34, or dsC
prior to vTRPV4 infection. At 48 h p.i. the cells and medium were
collected. Plaque assays were performed on the medium to
quantify the infectious BVs (Fig. 5A). The average titers of the
BV in the medium of Sf21 cells transfected with ds33, ds34, or dsC
were 4.6106, 3.3105, or 6.5107 pfu/ml, respectively. Thus
the infectious BVs released in the media from cells transfected
with ds33 or ds34 were 14 or 197 fold less than the BVs released
from the cells transfected with dsC, respectively. DNA was
extracted from the cells and a quantitative PCR (qPCR) was
performed. We found that there was a subtle increase in the
mean levels of virus DNA from cells transfected with ds33
(1.3 fold increase) or ds34 (1.7 fold increase) when compared
with dsC (Fig. 5C). The increase in cellular virus DNA was
statistically signiﬁcant for ds34-treated cells (po0.05), but not
for ds33-treated cells. A second qPCR performed on BV DNA,
extracted from fractions of medium collected and used for plaque
assays, showed 2 or 3.6 fold reduction in virus DNA when ds33 or
ds34 were used, respectively (Fig. 5D), providing further evidence
that BV production is reduced when ORFs 33 or 34 are knocked-
down . The data were normalized to the 28S gene to eliminate any
background contamination from cellular DNA obtained during the
DNA extraction from the BVs. When we compared the BV titers
from vTRPV4- and v33KO-infected Sf21 cells there were no signi-
ﬁcant differences (Fig. 5B). These data suggested that the reduced
titers observed when cells were transfected with ds33 or ds34
were most likely the result of knocking down ORF34 expression,
rather than a consequence of knocking down ORF33 expression.
Reducing the levels of an essential gene reduced BV titers and
appeared to increase the intracellular levels of virus DNA.
This suggested that increased viral DNA in the nucleus providing
additional template for gene transcription could be a possible
mechanism for enhanced reporter gene expression. To test
this, expression of the major viral capsid protein, vp39, wasknocked down with dsRNA prior to infections with vTRPV4, to
reduce BV production. Expression of TRPV4 was not enhanced
(Supplementary Fig. 1A). When virus DNA was measured by
qPCR, there was a signiﬁcant reduction in BV DNA relative to
controls and a small, although not signiﬁcant, increase in intra-
cellular virus DNA (Supplementary Fig. 1B). These results indicate
that reducing virus BV production may result in a small increase
in intracellular virus DNA, but does not enhance heterologous
gene expression. Although this experiment does not rule out
the possibility that increased template DNA may contribute
to enhanced gene expression from the polh promoter in ORF34
knockdown experiments, it suggests that it is not a key mechanism.
Knockdown of ORF34 enhances TRPV4-EGFP expression in cells
infected with v33KO
To verify the role of reduced expression of ORF34 in enhancing
expression of the TRPV4-EGFP reporter, we conducted RNAi
experiments on v33KO-infected Sf21 cells. Cells were transfected
with ds33 or ds34 prior to infection, as previously described, and
ﬂuorescent intensity was measured at 48 h p.i. by ﬂow cytometry.
We found that ds34 but not ds33 signiﬁcantly enhanced TRPV4-
EGFP expression relative to controls (Fig. 6A). We veriﬁed the
reduction in ORF34 transcripts by RT-PCR (Fig. 6B). Because
the two transcriptional start-sites of ubi map to immediately
upstream and within ORF34 (Guarino, 1990), we also examined
ubi transcription by RT-PCR . We found no difference in the levels
of ubi transcripts relative to 28S controls (Fig. 6B). These data
support the idea that enhanced TRPV4-EGFP expression is the
result of reducing the levels of ORF34 transcripts.
ORF34 is an essential gene required for budded virus production
To conﬁrm that ORF34 is an essential gene, as suggested
by our inability to obtain recombinant viruses when cells were
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we constructed ORF34 deletion bacmids in the same manner as
the TRPV4-EGFF-expressing v34KO (Fig. 7A). Successful deletion
of ORF34 was conﬁrmed by PCR (Fig. 7B). An EGFP reporter driven
by the polh promoter was then inserted at the polh locus
either alone or together with ORF34 driven by its own promoterFig. 6. Silencing ORF34 with dsRNA enhanced expression levels of TRPV4 protein
in Sf21 cells infected with an ORF33 knockout virus. (A) Sf21 cells were
transfected with 2 mg dsRNA and 24 h later cells were infected with v33KO. Flow
cytometry was used to analyze the relative GFP intensity at 48 h p.i. CF, cellfectin
transfection reagent. (B) The expression levels of ORF34 and ubi were determined
by RT-PCR. After transfection with dsRNA, cells were infected with v33KO and
RNA was isolated at 48 h p.i. M, 100 bp ladder; NC, negative control. ** indicate
Po 0.01 (t-test).
Fig. 7. Construction of an ORF34-knockout bacmid (KO34) and rescue bacmids. (A) A
CF and CR indicate the primers located outside the ORF34 deletion region (from 28494
of ORF34 with primers CF and CR. (C) Diagram showing ORF34 rescue constructs. G
(KO34-polhGFP). ORF34 under its own promoter was cloned downstream of EGFP in
Res34R). (D) PCR analysis of the rescue bacmids with the CF and CR primers. M, 100 bp
KO34 bacmid, used as a positive control; NC, negative control using water as template(Fig. 7C). Two different rescue constructs were made, orienting
ORF34 in either the same direction as GFP (KO34-polhGFP-
Res34F) or in the opposite orientation (KO34-polhGFP-Res34R)
(Fig. 7B). Successful deletion of ORF34 and re-insertion were
conﬁrmed by PCR (Fig. 7D).
Sf21 cells were transfected with the bacmids and observed
over time post-transfection . Images taken at 72 h post transfec-
tion are shown in Fig. 8A. Similar to our observations of cells
transfected with ORF 34 knock-out bacmids expressing TRPV4-
EGFP (v34KO, v34/33KO, and v34/33/FGFKO) (Fig. 4A), only single
ﬂuorescent cells were observed when cells were transfected with
KO34-polhGFP (KO34). In contrast, ﬂuorescent plaques were
observed in cells transfected with both rescue bacmids. When
supernatants from these transfections were used to infect fresh
monolayers of Sf21 cells, no ﬂuorescent cells were observed for
KO34-polhGFP, whereas robust infections were initiated with
supernatants from both rescue bacmid transfections (Fig. 8B).
DNA was prepared from the supernatants of infected cells
harvested at 72 h p.i. and analyzed for the presence of BV by
PCR (Fig. 8C) and qPCR (Fig. 8D) using primers targeting vp39.
No ampliﬁcation was observed from KO34-polhGFP samples,
whereas all of the samples of rescue viruses had levels of virus
DNA orders of magnitude higher than KO34-polhGFP .
Because our results conﬂicted with those reported by (Cai
et al., 2012), we re-examined our constructs and our data.
The region of ORF34 deleted for each of our constructs, v34KO,
v34/33KO, v34/33/FGFKO, and KO34 (Fig. 4A and Fig. 7A) was
nearly identical to their deletion, which was in the same region
but was more extensive comprising an additional 48 nucleotides,
47 towards the 30end, yet in contrast we were unable to isolate
deletion viruses. We came up with two possible explanations for
these differences. Perhaps a portion of the remaining ORF34 gene
was expressed in their constructs and provided some essential
function allowing viable virus to be recovered. Another possibility
was that intact ORF34 was present at low levels. We hypothesized
that the differences in levels of infection, the presence of plaques,
and the ability to recover infectious virus was due to low levels of
bacmid DNA with intact ORF34 in the transfections. To determinediagram showing the knockout of the ORF34 gene by insertion of the CAT gene.
to 28692, Gene accession no. NC_001623). (B) PCR was used to verify the deletion
FP under polh promoter was put into the polh locus of the KO34 as a control
either the forward (KO34-polhGFP-Res34F) or reverse direction (KO34-polhGFP-
ladder; 1, KO34-polhGFP; 2, KO34-polhGFP-Res34F; 3, KO34-polhGFP-Res34R; the
.
Fig. 8. Analysis of virus propagation and BV production in Sf21 cells. (A) Sf21 cells were transfected with the knockout or rescue bacmids and cells were visualized for GFP
ﬂuorescence under microscope at 72 h post transfection. (B) The supernatant of transfected cells were collected at 96 h post transfection. Cells were removed and half the
volume of supernatant was used to infect Sf21 cells. Images were taken at 48 h p.i. (C) DNA was isolated from BV harvested from the rescue virus infected Sf21 cells at 72 h
p.i. and PCR was used to detect the virus vp39 gene. M, 100 bp ladder; 1, KO34-polhGFP; 2, KO34-polhGFP-Res34F; 3, KO34-polhGFP-Res34R; PC, Wild type Acbacmid was
used as a positive control; NC, negative control using water as template. (D) The result of real-time PCR analyzing the relative fold change of the BV production. DNA was
extracted from the BV collected at 72 h p.i. and primers qvp39-F and qvp-39-R were used for real-time PCR. KO34, KO34-polhGFP; Res34F, KO34-polhGFP-Res34F; Res34R,
KO34-polhGFP-Res34R. ** indicate Po 0.01 (t-test).
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with KO34 bacmid and AcMNPV bacmid (AcBac) (10:1) and
compared these cells with those transfected with KO34 or Res34F
over time. We observed virus spread and plaque formation, but at
a slower rate than in cells transfected with Res34F (Supplemen-
tary Fig. 2). Based on these observations we repeated transfection
experiments with KO34, Res34F, and AcBac, and titrated the
supernatants by plaque assay. In this experiment we observed
15 small plaques on the titration plates from undiluted transfec-
tion supernatants from KO34 transfected cells harvested at 72 h
post transfection (Supplementary Fig. 3A). We harvested the
transfection supernatants from each time point and infected
fresh cells with equal volumes (200 ml) of the supernatants.
The supernatants from the infected cells were harvested at 48 h
pi and titrated. We did not observe any plaques in cells infected
with supernatants from KO34 transfections (Supplementary
Fig. 3B).We picked the ﬁve largest plaques from the titration of KO34
transfection supernatants from 72 h post transfection and used
them to infect fresh cells. By using sparsely seeded Sf21 cells, to
reduce overgrowth during a long incubation, we were able to
amplify two of these plaques. After one week, infection from
plaque 1 had spread to nearly 50% of the cells in a 6-well plate,
whereas infection from plaque 2 was closer to 20% of the cells.
We then examined total cellular DNA and BV DNA from these
ampliﬁed plaques for the presence of ORF34 by PCR and qPCR,
using primers ORF34F(CF) and ORF34R(CR) or qORF34F(q34F)
and qORF34R(q34R), respectively (Supplementary Fig. 4A).
We observed a faint band indicative of intact ORF34 in PCR
ampliﬁed cellular DNA from plaque 1, but not from plaque 2
(Supplementary Fig. 4B, arrowhead). When we used qPCR target-
ing ORF34 we observed DNA ampliﬁcation from both plaque 1
(Ct 26.9) and plaque 2 (Ct 26.9) at appoximately106-fold lower
levels than for Res34F (Ct 10.0) (Supplementary Fig. 4C). We were
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(Ct 29.9), but not from plaque 2, at levels around 3105-fold
lower than Res34F (Ct 15.0) (Supplementary Fig. 4D). These data
indicated that low levels of ORF34 DNA were present in the small
plaques we were able to amplify, and these low levels were
sufﬁcient to support virus spread and plaque formation.
To determine if ORF34 affected viral DNA replication and
accumulation, qPCR was conducted to detect vp39 on DNA
isolated from cells transfected with KO34 and ORF34 rescue
(Res34F) bacmids at 24 and 48 h post transfection. Both the
intracellular and supernatant qPCR data were normalized to the
28S gene to eliminate any background. The levels of intracellular
virus DNA in cells transfected with KO34 at 24 and 48 h post
transfection were similar to Res34 at 24 h post transcription, with
a small increase between 24 and 48, reﬂecting DNA replication in
individually transfected cells. In contrast, there was an over 100
fold increase in intracellular virus DNA in cells transfected with
the rescue bacmid, as the result of virus spread and DNA
replication in the newly infected cells (Supplementary Fig. 5A
and B). Supernatants from these KO34 and Res34F transfections
were also analyzed by qPCR for the presence of viral DNA as
evidence for the presence of BVs. An increase in viral DNA in the
supernatants of the rescue bacmid, but not KO34 was observedFig. 9. Transmission electron microscopy of KO34 and Res34F transfected cells 48 h pos
cells. (C) BV in rescue bacmid transfected cells, arrowhead indicates small vesicles a
Enveloped nucleocapsids (arrows) in the nucleus of rescue (E) and KO34 transfected cell
n¼nucleus; cy¼cytoplasm; ne¼nuclear envelope. White bars indicate scale.(Supplementary Fig. 5C). The differences in supernatant DNA in
KO34 samples from 24 to 48 h post transfection is most likely the
result of difﬁculties in DNA isolation owing to lack of or low levels
of BV in these samples. Western blots of pelleted transfection
supernatants were also performed to see if BV proteins could be
detected. In these experiments we detected vp39 and gp64
protein expression from Res34F but not KO34 (Supplementary
Fig. 6). Together with the ORF34 knockdown experiments where
BV was reduced over 100 fold (Fig. 5A) and lack of evidence for
infectious virus production in cells transfected with KO34 bac-
mids (Fig. 8D) these data suggest that ORF34 plays a role in BV
production.
Transmission electron microscopy studies provide evidence for DNA
replication and suggest lack of virus budding
To better understand the defect in BV production that occurs
when ORF34 expression is reduced or eliminated, transfected cells
were examined by transmission electron microscopy. Two sets
of experiments were done. For knockdown experiments ORF34
dsRNA was used to knockdown ORF34 expression prior to infection
with wt AcMNPV and compared with cells transfected with
dsCAT RNA prior to infection. Cells were processed 48 h p. i. Fort transfection. Virogenic stroma (vs) in rescue (A) and (B) KO34 bacmid transfected
nd arrows indicate BV. (D) Vesicles observed in KO34 transfected cells (arrows).
s (F), arrowhead indicates nucleocapsid array in rescue bacmid transfected cells (E).
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and Res34F bacmids and processed at 48 h post transfection.
In ORF34 knockdown experiments polyhedra formed but envel-
oped virions were not occluded (data not shown). In comparing
cells transfected with KO34 and ORF34 repair Res34F we observed
that cells transfected with both KO and Res34F contained virogenic
stroma indicating that virus DNA was replicated (Fig. 9A and B). BV
were clearly observed in cells transfected with the rescue bacmid
(Fig. 9C, arrows), but we were unable to ﬁnd clear evidence for BV
budding from cells transfected with KO34. However we observed
what appeared to be membrane vesicles in the cytoplasm of KO34
transfected cells (Fig. 9D, arrows). These were larger than similar
structures observed in rescue bacmid transfected cells (Fig. 9C,
arrowhead). In the nucleus of cells transfected with the rescue
bacmid, capsid structures were observed in arrays associated with
membranes (Fig. 9 E, arrowhead), but similar arrays were not
observed in KO34 transfected cells. However, individual capsids
were observed in KO34 transfected cells near the virogenic stroma
(data not shown). Enveloped nucleocapsids were observed in both
KO34 and rescue bacmid transfected cells (Fig. 9E and F, arrows).
However, it was unclear if the apparent nucleocapsids in the KO34
transfected cells contained DNA.Discussion
As a result of an RNAi screen of AcMNPV ORFs, we found that
reducing ORF34 expression via dsRNA knock-down signiﬁcantly
increased the expression of a TRPV4-EGFP reporter driven by the
polh promoter in a recombinant AcMNPV. ORF34 is part of a
transcriptional unit that includes two other ORFs, ORF32 (fgf),
and ORF33. In a previous study, three abundant transcripts were
identiﬁed on northern blots when probes complementary to
ORF33 and FGF were used (Detvisitsakun et al., 2005) (Fig. 2A).
Two of them, 1.4 and 3.1 kb transcripts, were overlapping and
spanned both ORF33 and FGF. Based on one-step RT-PCR data, we
found that the 3.1 kb transcript also spans ORF34 (Fig. 2C). When
cells were transfected with ds33 expression of all three ORFs was
reduced (Figs. 2 and 3). However, ORF34 transcripts were reduced
less relative to either ORF33 or fgf transcripts (Fig. 3), indicating
that a subset of transcripts in this region include only ORF34
(Fig. 2A, transcript X). Reducing transcription of these genes
by transfecting ds33 also improved the expression of another
IMP, CNR2 a G-protein coupled receptor, as well as that of
cytoplasmic EGFP (Fig. 1), indicating that enhanced expression
was not speciﬁc for IMPs.
Mutations of ORF33, FGF and ORF34 singly or in combination
using vTRPV4 bacmids resulted in reduced TRPV-GFP expression
when ORF33 or FGF were mutated (Fig. 4B). Although the previous
study showed no negative impact on the virus replication or
budded virus production when FGF was deleted (Detvisitsakun
et al., 2006), our study is the ﬁrst to demonstrate that deleting FGF
may have a slight negative effect on the expression of an IMP using
BEVS. The reasons for this are unknown. In contrast to FGF and
ORF33, we were unable to obtain any recombinant viruses in
which ORF34 had been disrupted. Although individual green
ﬂuorescent cells were observed in Sf21 cells transfected with each
of the bacmids with ORF34 disruptions (Fig. 4A, boxed), viruses
lacking ORF34 could not be propagated. This indicated that ORF34
was essential.
Our data supports the idea that ORF34 is essential, but it
may not be required at high levels. We hypothesized that ds33
knocked down a transcript(s) comprising both ORF33 and ORF34,
but low level of these transcripts remaining were sufﬁcient to
insure virus viability. Because ORF34 deletions could not be
obtained we explored this possibility using RNAi targetingORF34. Targeting ORF34 alone or in combination with ORF33
and/or FGF enhanced TRPV4-EGFP expression to the same levels
as ds33 (Fig. 4C). These data support the idea that enhanced
expression of TRPV4-EGFP was due to the reduced expression of
ORF34. Knockdown of ORF34 expression in v33KO-infected cells
enhanced TRPV4-EGFP expression conﬁrming the role of reduced
ORF34 transcripts in enhancing protein expression (Fig. 6A).
When we examined the kinetics of BV production, we found
that transfecting cells with either ds33 or ds34 resulted in
signiﬁcantly reduced BV yields (Fig. 5A). However a similar
reduction in BV was not observed in cells infected with the
ORF33 knockout virus v33KO (Fig. 5B), indicating that the reduc-
tion in BV production resulted from reduced ORF34 expression
and not from changes in ORF33 expression. Because a previous
report showed that a frame-shift mutation in ubi (ORF35) resulted
in viable virus but with reduced BV titers (Reilly and Guarino,
1996), we considered the possibility that reduced BV production
was due to knock-down of ubi. UBI is encoded on the strand
complementary to FGF, ORF33 and ORF34 on the virus genome,
immediately upstream of ORF34 with no overlap (Ayres et al.,
1994; Guarino, 1990). It is transcribed from two late promoter
elements that map to a site immediately upstream of ORF34 and
to a site within the ORF34 coding sequence, respectively (Guarino,
1990). The double-stranded RNA targeting ORF34 was designed to
exclude the ubi transcriptional start sites, and knocking down
ORF34 expression with ds34 did not reduce ubi transcription
(Fig. 6B). However, our results provide an explanation for why an
AcMNPV ubi deletion could not be constructed (Reilly and
Guarino, 1996). Deleting ubi would effectively eliminate both late
transcriptional start sites for orf34, and an early start site (Cai
et al., 2012), which lie within the ubi ORF. In addition, because the
frame-shift eliminated the proximal orf34 transcriptional start
site it also explains the reduced BV titers in cells infected with ubi
frame-shift mutants (Reilly and Guarino, 1996). In contrast, when
ubi was disrupted in BmNPV it did not affect BV production
(Katsuma et al., 2011). Examination of the region of the BmNPV
sequence encompassing the initiator codon of Bm25 (the
Ac34 homolog), ubi, and ubi upstream sequence (Accession no.
NC_0011962; nucleotides 25012–25500 ) revealed that the single
late transcriptional start site upstream of Bm25was not altered by
the disruption strategy used in this study.
Another report on the role of AcMNPV ORF34 was recently
published (Cai et al., 2012). In agreement with our study they saw
no effects of ORF34 deletion on virus DNA replication. In contrast
to our study, they observed BV in Ac34KO bacmid transfections,
although BV production was delayed and titers reduced relative
to rescue bacmids. They were also able to recover recombinant
viruses. This was very puzzling considering that the ORF34
mutations were quite similar to ours, but we could not recover
virus and only rarely observed plaques, which were always very
small. Based on our dsRNA knockdown studies only low levels of
ORF34 were required for BV production and virus spread. Thus,
one possible explanation for virus recovery might be the presence
of low levels of ORF34 or truncated ORF34 remaining in the
deletion being expressed. Spiking KO34 transfection with bacmids
having intact ORF34 gave a phenotype consistent with this
hypothesis (Supplementary Fig. 2). In addition, we succeeded in
amplifying two of the small plaques we occasionally observed in
transfections with our ORF34KO bacmids. We detected low levels
of ORF34 in cells infected with each of these (Supplementary
Fig. 4). These results support the plausibility of this hypothesis.
Failed attempts to generate ORF34-knockout viruses indicated
that ORF34 was an essential gene. Reduced virus titers in ds34
transfected cells (Fig. 5A) suggested a role for ORF34 in BV
infectivity, virion packaging, trafﬁcking from nucleus to the
plasma membrane, or in budding. Transfecting cells with ORF34
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for the spread of virus infection from initially transfected cells
(Fig. 8A). The supernatants from ORF34-knockout bacmid trans-
fected cells were unable to infect fresh cells, indicating that
infectious BV was not produced (Fig. 8B–D ). Electron microscopy
showed virus DNA replication and formation of capsid structures,
although we were unable to unequivocally determine if the
capsids contained DNA. We were unable to ﬁnd clear evidence
for BV by electron microscopy, or by western blot analysis
suggesting a role for ORF34 in budding. It is possible that ORF34
may also play a role in DNA packaging. Further study is needed to
determine the speciﬁc role of ORF34 in the baculovirus lifecycle
and how reducing its expression enhances the expression of
heterologous proteins.Materials and methods
Cells and viruses
Spodoptera frugiperda IPLB-Sf21 cells (Vaughn et al., 1977) were
maintained at 27 1C in TC100 medium (United States Biologicals)
supplemented with 10% fetal bovine serum (Atlanta Biologicals).
vEGFP a recombinant AcMNPV expressing EGFP from the polh
promoter was a gift from Xiao-Wen Cheng (Miami U., Oxford,
OH). vTRPV4 and vCNR2 were constructed using the Bac-to-Bac
and Gateway systems (Invitrogen). cDNA clones of TRPV4 (Acces-
sion no. NM_021625.4) and CNR2 (Accession no. BC069722) were
obtained from the American Type Culture Collection and ampli-
ﬁed by PCR to incorporate attB sites and inserted into pDONR201.
The PCR primers were: TRPV4FP 50-GGGGACAAGTTTGTA-
CAAAAAAGCAGGCTTCACCatggcggattccagcgaagg-30;
TRPV4RP 50-GGGGACCACTTTGTACAAGAAAGCTGGGTCgagcg-
gggcgtcctcagtc-30; CNR2FP 50-GGGGACAAGTTTGTACAAAAAAGC-
AGGCTCCatggaggaatgctgggtgacagagat-30; and
CNR2RP 50-GGGGACCACTTTGTACAAGAAAGCTGGGTAgcaatca-
gagaggtctagatctctgga-30.
The TRPV4 and CNR2 coding sequences were transferred
from the donor plasmids to a modiﬁed pDEST8 vector, to generate
an in-frame fusion to an EGFP-His-tag with a TEV protease site
between the cloned genes and EGFP. These constructs, pDEST-
TRPV4 and pDEST-CNR2 were used to generate the recombinant
viruses according to the Bac-to-Bac manual (Invitrogen). Recom-
binant viruses were plaque puriﬁed, ampliﬁed, and veriﬁed by
sequencing. Infections and plaque assays followed standard
procedures (O’Reilly et al., 1992). Plaque assays were performed
in duplicate on three independent samples.
Virus gene deletions
To produce vTRPV4 with gene deletions, l Red recombination
was used to replace the targeted ORFs with a CAT cassette in
the TRPV4 bacmid as previously described (Datsenko and
Wanner, 2000; Vanarsdall et al., 2004). The TRPV4 bacmid DNA
was electroporated into, and subsequently maintained in, the
BW25113/pKD46 strain. Primers were designed to amplify CAT
gene with ﬂanking sequences (50 bp) homologous to the ORFs
targeted for deletion. A total of 100 ng of the PCR products were
electroporated into 40 ml of competent BW25113/pKD46/TRPV4
cells. The primers used to generate the knockout viruses were as
the following: 1–CatF33 , ATGTGGACGTTACAGCAGCCCGATTTG-
TATGCGTACG CGGTTCATGACGGCGGTGTAGGCTGGAGCTGCTTC;
CatR33, GTTGTATAAACTGCTC.
TGGCGTGTAAAACTGCAGACTTAAGTTTTTTGCAAAATGGGAATT-
AGCCATGGTCC (v33KO); 2–CatF33M , CTTCCGTGCGCACACAAG
CTAAAGCGTTTGTACGAATTAGGC.TACGATTTGTGTAGGCTGGAGCTGCTTC; CatR33M, AATATGCG-
TAAACTGTTTGGCC.
ATCTCGCGCCACATTCCCGTGTCGGGCTATGGGAATTAGCCATG-
GTCC (v33MKO); 3–CatF34 , GAGGCTGACGACGATTTTAAGG;TG-
AATCAAACGCGGAATCTAAGCTGCAA.
GTGTAGGCTGGAGCTGCTTC; CatR34, CTCGACGTAGTTGTTG-
CATGTTATGTCGCG.
TGTGCCGCGATACGCGTGATATGGGAATTAGCCATGGTCC
(v34MKO); 4–CatFFGF , GAAATCGCATCGTCATTCAAAACGCCAT-
CACGTGTGTGTACCTGTGCATGGTGTAGGCTGGAGCTGCTTC; CatR-
FGF, GGAGTACCGTCGTTCTTCAGTGCCACATACGTCAAC.
TTGCGATCGTACACATGGGAATTAGCCATGGTCC (vFGFMKO);
5–CatF34 and CatR33M (v34/33KO); and 6–CatF34 and CatRFGF
(v34/33/FGFKO). Gene deletions in positive colonies were veriﬁed
using the following primers: 1–Orf33F , GTTACAGCAGCCCGAT-
TTGT; Orf33R, TGCTCTGGCGTGTAAAACTG (bac33MKO);
2–ORF34F , GACAACGGTTGCTGTGAATG; ORF34R, GTGCTCGACG-
TAGTTGTTGC (bac34MKO); 3–FGFF , GACGGAGCTGTTTACGGAAC;
FGFR, GACATTTACGATGGCG.
AACA (bacFGFMKO); 4–Orf33F and FGFR (v34/33KO and v34/
33/FGFKO).
ORF34 Knockout virus (KO34) was constructed the same way
using the l Red recombination system. CatF34 and CatR34
(v34MKO) primers were used to replace the region from 28494
to 28692 of ORF34 with a CAT cassette in the Acbacmid. To make
the ORF34 rescue viruses, EGFP under the polh promoter and
ORF34 under its own promoter were inserted to the polh locus
using the Bac-to-Bac system. The primers used for cloning ORF34
into the pDEST 8 vector were ResORF34F-FP (50-GGGAAGCTTGGT-
TAGCGATAATACACAAG-30) and ResORF34F-RP (50-GGGACTAGTT-
TACTCAAAGTCCATCAATTC-30); ResORF34R-FP 50-GGGAAGCTTTT-
ACTCAAAGTCCATCAATTC-30 and ResORF34R-RP GGGACTAGTGG-
TTAGCGATAATACACAAG-30). The deletion and rescue of ORF34
were veriﬁed by PCR using primers ORF34F and ORF34R.RNAi experiments
Unless speciﬁed otherwise, RNAi experiments were performed
in 24 well microtiter plates. A total of 2105 Sf21 cells were
seeded per well and 5 mg of each of the dsRNAs were transfected
into the Sf21 cells using 5 ml cellfectin II according to the
instructions of the cellfectin II manual (Invitrogen). The transfec-
tion was conducted overnight (18 h) at 27 1C on a rocker platform
at 2.5 rpm. The transfection mixture was removed and the cells
were infected with virus at MOI of 5. For transfections with
multiple dsRNAs, 5 mg of each dsRNA was transfected and the
amount of cellfectin II was increased proportionally. The primers
used for synthesis of dsRNA are listed below. dsGFP-FP 50-
TAATACGACTCACTATAGGGACGTAAACGGCCACAAGTT-30, dsGFP-
RP 50-TAATACGACTCACTATAGGGTGTTCTGCTGGTAGTGGTCG-30,
ds33FP 50-TAATACGACTCACTATAGGGACGGCGCTAAAAGAACCAA-
A-30, ds33RP 5-TAATACGACTCACTATAGGGGCTCTGGCGTGTAAAA-
CTGC-30, ds34FP 50-TAATACGACTCACTATAGGGCCTTCAACGGCA-
ATTGATTT-30, ds34RP 50-TAATACGACTCACTATAGGGGCCATTAGA-
TCGGATAGCGA-30, dsCAT-FP 50TAATACGACTCACTATAGGGATCC-
CAATGGCATCGTAAAG-30, dsCAT-RP 50-TAATACGACTCACTATAGG-
GATCACAAACGGCATGATGAA-30, dsFGF-FP 5-TAATACGACTCACT-
ATAGGGTCGCTTGCTGGCACTTGTAG-30, dsFGF-RP 50-TAATACGAC-
TCACTATAGGGTGACATTTACGATGGCGAACA-30, ds39-FP 50-TAA-
TACGACTCACTATAGGGTTTTAATTCCAAGCGCAACC-30, ds39-RP 50-
TAATACGACTCACTATAGGGAATTCCTCCGTGTCGATTTG-30, ds39*-
FP 50-TAATACGACTCACTATAGGGATGCAAGCCGAACAGCTAAT-30,
ds39*-RP 50-TAATACGACTCACTATAGGGGCAAACGATTGGGTT-
GACTT-30.
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AcMNPV bacmid DNA was used as a template to produce PCR
templates to synthesize dsRNA targeting AcMNPV ORFs. The
primers used to generate the PCR templates are listed in Supple-
mentary Table 1. Megascript kit (Ambion) was used to synthesize
the dsRNAs according to the instruction manual. The RNAi screen
was performed in triplicate as described above and the ﬂuores-
cence data were collected at 48 h p.i. using a plate reader (see
below).
Plate reader
SpectraMaxs M5 Microplate Reader (Molecular Devices) was
used to measure the mean ﬂuorescence intensity in Sf21 cells.
Fluorescence was measured from the bottom side of the well at
530 nm. For each well, 100 reads were taken and averages were
calculated. The data were collected from three independent
samples. The signiﬁcant difference between controls (dsC or
dsCAT) and the experiments was calculated by t-test.
Fluorescent-Activated Cell Sorter (FACS)
The median ﬂuorescence intensity (MFI) representing the
average ﬂuorescence intensity that used to compare the cellular
EGFP expression was computed using the Fluorescent-Activated
Cell Sorter (FACS). Flow cytometry was performed using a BD
FACS Vantage SE instrument (BD-Biosciences, San Jose, CA). Light
scatter was produced and ﬂuorescence was excited using an
argon-ion laser at 100 mW and ﬂuorescence detection was done
using a 530/30 nm band pass ﬁlter. Data were collected and
analyzed using ‘‘Cell Quest Version 3.3’’ (BD-Biosciences). For
each sample, 15,000 cells were analyzed.
In-gel ﬂuorescence
Cells from ds33 and dsC treatments were collected at 48 h p.i.
and washed with 1 PBS buffer (pH 7.4) twice and resuspended
in 50 ml of 1 PBS. Cells were lysed with equal volume (50 ml) of
solubilization buffer 200 mM Tris–HCl (pH8.8), 20% Glycerol,
5 mM EDTA (pH 8.0), 0.02% bromophenol blue, and stored at
20 1C; 200 ml 20% SDS, and 100 ml 0.5 M DDT were added before
loading the gels (Drew et al., 2006). A total of 20 ml of each
sample was loaded on 10% SDS-PAGE . Following electrophoresis,
images were acquired by VersaDocTM imaging system (BioRad).
Relative ﬂuorescent intensity (RFI) was measured by Quantity
One software.
Western blot analysis
Total proteins were extracted from ds33 and dsC treated cells
at 48 h p.i. The cell pellets were resuspended in 50 ml 1 PBS
(pH 7.4) and lysed using 50 ml of solubilization buffer (see In-gel
Fluorescence). All samples were incubated on ice for 30–45 min.
Samples were boiled for 5 min and spun down for loading. A total
of 20 ml of each sample was resolved on a 10% SDS-PAGE gel
and transferred to a PVDF membrane (Amersham). The TRPV4-
EGFP-His fusion protein was detected with mouse monoclonal
anti-His antibody (Qiagen) diluted 1:2000 followed by anti-
mouse IgG (1:1000 dilution) as the secondary antibody (Thermo
Scientiﬁc). Anti-VP39 and anti-GP64 antibody were diluted by
1:2000 or 1:500 followed by anti-rabbit or anti-mouse IgG
respectively. Visualization was performed by SuperSignal West
Pico Chemiluminescent Substrate (Thermo Scientiﬁc) according to
instructions. VersaDoc MP4000 system (Bio-Rad) was used toimage the western-blot . Relative intensity (RI) was measured by
Quantity One software.
Total RNA extraction
A total of 0.8106 Sf21 cells in each well of the 6-well plate
were transfected overnight (18 h) with 20 mg dsRNAs and 20 ml
cellfectin II followed by 1 h infection with vTRPV4. Total RNA was
extracted from the cells at 48 h p.i. following the instruction
manual of RNeasy Mini kit (Qiagen). Samples were digested twice
with the RNase-Free DNase set (Qiagen).
One-step reverse transcriptase polymerase chain reaction (RT-PCR)
The reaction was conducted according to Access RT-PCR kit
(Promega) with modiﬁcations. A total of 100 ng of DNA-free total
RNAs were used and the reaction was as the following: 10.6 ml
Nuclease-Free Water, 4 ml AMV/Tﬂ 5 Reaction Buffer, 0.4 ml
dNTP Mix (10 mM each dNTP), 1 ml forward primer (10 mM),
1 ml reverse primer (10 mM), 1.2 ml 25 mM MgSO4, 0.4 ml AMV
Reverse Transcriptase (5 u/ml), and 0.4 ml Tﬂ DNA Polymerase
(5 u/ml). The thermocycler (PerkinElmer) program was as the
following: 45 1C for 45 min; 94 1C for 2 min; 22 cycles of 94 1C
for 30 s, 60 1C for 1 min, and 72 1C for 5 min; and 72 1C for 7 min.
The primers were the same as those used for generating PCR
products for gene deletions, see above FGFR(R3), FGFF (F3) Orf33R
(R2), Orf33F (F2), ORF34F(F1) and ORF34R (R1). The primers for
determining virus ubi expression were Ubi-FP 50-GCCGAAACG-
GAACCCGCAGA-30 and Ubi-RP 50-GAATCTTCCAGTTGTTTGCCCGC-
30. 28S RNA ampliﬁed with primer F (AGCTGGCTTGATCCAGATGT)
and primer R (AACCAAATGTCCGAAACTGC) was used as a control.
Quantitative real-time polymerase chain reaction
For qRT-PCR a total of 1 mg of the DNase-treated total RNA was
used for cDNA synthesis following the manual of the iScript cDNA
synthesis kit (Bio-Rad). The qPCR was conducted using Power
SYBR Green PCR Master Mix (Applied Biosystems). Three biologi-
cal samples for each treatment and two technical replicates were
used in the qRT-PCR . For each sample, 10 ng RNA-equivalent
cDNA were used as a template using 300 nM of each primer
(forward and reverse) in addition to the 2 Power SYBR Green
PCR Master Mix in a 15 ml reaction. The relative expression of
each gene was calculated according to the 2DDCt method (Livak
and Schmittgen, 2001; Schmittgen and Livak, 2008). 28S RNA was
used as a reference. The relative expression of transcripts in the
cells transfected with dsC was considered to be 1 and the relative
expression of transcripts in the cells transfected with ds33 was
calculated accordingly. qRT-PCR was done on the 24 h p.i. and
48 h p.i. samples. A Student’s t-test was used to determine the
signiﬁcant differences between samples. Primers used for qRT-
PCR were the following: qORF33F, CACGGTCCAAATTTCCAAAAA;
qORF33R, TCGTACAAACGCTTTAGCTTGTG; qORF34F, GACTGG-
TTGTGGTGTGATTTTCA; qORF34R, GCTCGACGTAGTTGTTGCATGT;
qFGF-F, GAACCATTGAATCGGACAACGT; qFGF-R, AATGACGATGC-
GATTTCTGTCA; qEGFP-F, CTGCTGCCCGACAACCA; qEGFP-R, TGT-
GATCGCGCTTCTCGTT; q28s_163962980_F_15, CTGGCTTGATCCA-
GATGTTCAG; q28s_163962980_R_72, GGATCGATAGGCCGTGCTT.
Viral DNA analysis
A total of 3.5105 Sf21 cells were seeded in each well of
12-well plate. In three independent experiments, cells were
transfected overnight with 10 mg of ds33, ds34, or dsC and then
infected with vTRPV4 at MOI of 5. At 48 h p.i., cells were collected
and washed with 1 PBS (pH 7.4) and 100 ml of the media were
T.Z. Salem et al. / Virology 435 (2013) 225–238238saved for plaque assay. BVs were recovered from equal volumes of
supernatant by centrifugation (O’Reilly et al., 1992). DNA was
extracted from both the cells and BV according to the manual of
the DNeasy Blood & Tissue kit (Qiagen). The mean relative fold
change of the vTRPV4 genome in cells was measured by qPCR (as
described above). Reactions used 50 ng of DNA extracted from
infected Sf21 cells as a template and primers targeting the major
capsid gene, vp39 (qvp39-F, TGTCGCGAGACGAATTGC; qvp39-R,
CCAGCACCGCCTCGAA). The 28S RNA gene was used as a reference
to normalize for any background from cellular DNA contamina-
tion obtained during BV DNA isolation.
Transmission electron microscopy
Transected cells were harvested at 48 h post transfection,
scraped from plates, washed in PBS (137 mM NaCl, 2.7 mM KCl,
10 mM Na2PO4, 2 mM KH2PO4, pH 7.4), and ﬁxed in 2.5% paraf-
ormaldehyde/2.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.4 (Electron Microscopy Sciences, Hatﬁeld, PA). The
ﬁxed cells were pelleted in 2% agarose, postﬁxed in 1% osmium
tetroxide (in 0.1 M cacodylate buffer), dehydrated in an acetone
series, and embedded in Poly/Bed 812 (Polysciences, Warrington,
PA). Ultrathin sections were prepared on a Power Tome XL
ultramicrotome (RMC, Boeckeler Instruments, Tucson, AZ) and
mounted on copper grids, stained for 30 min with saturated
aqueous uranyl acetate and 15 min with lead citrate. Sectioned
cell pellets were visualized using a JEOL100 CXII (Japan Electron
Optics Laboratories) transmission electron microscope. Images
were captured using a Soft Imaging Systems, MegaView III digital
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